Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label imatinib roll-over protocol for oncology patients previously enrolled in Novartis imatinib studies
2012-002540-25Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imatinib in cancer, sponsored by Novartis. Primary endpoint: Frequency and severity of adverse events and serious adverse events. Started Jan 2013; status: completed.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on 2012-002540-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002540-25.